Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nuevocor’s LMNA gene therapy is based on decades of research into fundamental mechanisms underlying LMNA-associated disease enabled by the development of novel technologies on the part of scientific co-founders Colin Stewart and Brian Burke. Together with the AAV gene therapy and cardiac disease modeling expertise of scientific co-founders Mark Kay and Jianming Jiang respectively, Nuevocor is well-positioned to cure LMNA a...
Nuevocor’s LMNA gene therapy is based on decades of research into fundamental mechanisms underlying LMNA-associated disease enabled by the development of novel technologies on the part of scientific co-founders Colin Stewart and Brian Burke. Together with the AAV gene therapy and cardiac disease modeling expertise of scientific co-founders Mark Kay and Jianming Jiang respectively, Nuevocor is well-positioned to cure LMNA and other genetic cardiomyopathies, amongst other cardiac diseases.

List your booth number for exhibitions, ask us